Astellas Pharma (4503N) Q2 2018 Earnings Report
1 Followers
MX:4503N Q2 2018 EPS Results
- Actual EPS
- MXN 4.25
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- MXN 3.25
MX:4503N Q2 2018 Revenue Results
- Actual Revenue
- MXN 52.94B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2018
- Date
- 10/31/2018
- Time
- TBA
- Conference Call
- Wednesday, October 31, 2018
MX:4503N Upcoming Earnings
Astellas Pharma's next earnings date is estimated for February 8, 2027, based on past reporting schedules.
Q2 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4503N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 08, 2027 | 2026 (Q3) | 7.05- | 6.59 | ― | ― |
| Nov 04, 2026 | 2026 (Q2) | 7.646.54 | 5.2 | 25.92% (+1.35) | |
| Aug 05, 2026 | 2026 (Q1) | 6.369.30 | 4.49 | 107.09% (+4.81) | |
| Apr 27, 2026 | 2025 (Q4) | 3.592.85 | 4.92 | -41.95% (-2.06) | |
| Feb 04, 2026 | 2025 (Q3) | 5.406.59 | -6.41 | 202.73% (+13.00) | |
| Oct 30, 2025 | 2025 (Q2) | 3.505.20 | 2.36 | 120.44% (+2.84) | |
| Jul 30, 2025 | 2025 (Q1) | 2.344.49 | 2.47 | 82.00% (+2.02) | |
| Apr 25, 2025 | 2024 (Q4) | 2.504.92 | -2.18 | 325.50% (+7.10) | |
| Feb 04, 2025 | 2024 (Q3) | 2.88-6.41 | 1.22 | -624.52% (-7.63) | |
| Oct 30, 2024 | 2024 (Q2) | 2.122.36 | -0.09 | 2607.50% (+2.45) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
